A detailed history of Pro Share Advisors LLC transactions in Novavax Inc stock. As of the latest transaction made, Pro Share Advisors LLC holds 48,937 shares of NVAX stock, worth $393,453. This represents 0.0% of its overall portfolio holdings.

Number of Shares
48,937
Previous 36,607 33.68%
Holding current value
$393,453
Previous $463,000 33.48%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$10.71 - $17.11 $132,054 - $210,966
12,330 Added 33.68%
48,937 $618,000
Q2 2024

Aug 13, 2024

SELL
$3.89 - $20.97 $2,318 - $12,498
-596 Reduced 1.6%
36,607 $463,000
Q1 2024

May 08, 2024

BUY
$3.76 - $6.02 $32,223 - $51,591
8,570 Added 29.93%
37,203 $177,000
Q4 2023

Feb 14, 2024

BUY
$4.8 - $7.67 $36,523 - $58,361
7,609 Added 36.19%
28,633 $137,000
Q3 2023

Nov 13, 2023

BUY
$6.81 - $9.74 $3,902 - $5,581
573 Added 2.8%
21,024 $152,000
Q2 2023

Aug 10, 2023

BUY
$6.67 - $9.52 $136,408 - $194,693
20,451 New
20,451 $151,000
Q2 2022

Aug 01, 2022

SELL
$36.28 - $75.29 $79,199 - $164,358
-2,183 Reduced 22.86%
7,365 $379,000
Q1 2022

May 10, 2022

SELL
$69.73 - $142.9 $208,980 - $428,271
-2,997 Reduced 23.89%
9,548 $703,000
Q4 2021

Feb 08, 2022

SELL
$134.56 - $217.97 $690,427 - $1.12 Million
-5,131 Reduced 29.03%
12,545 $1.8 Million
Q3 2021

Nov 12, 2021

BUY
$177.8 - $270.58 $337,286 - $513,290
1,897 Added 12.02%
17,676 $3.66 Million
Q2 2021

Aug 13, 2021

SELL
$121.0 - $257.67 $1.31 Million - $2.78 Million
-10,808 Reduced 40.65%
15,779 $3.35 Million
Q1 2021

May 14, 2021

BUY
$112.98 - $319.93 $231,609 - $655,856
2,050 Added 8.35%
26,587 $4.82 Million
Q4 2020

Feb 09, 2021

BUY
$78.74 - $139.5 $1.26 Million - $2.23 Million
16,006 Added 187.62%
24,537 $2.74 Million
Q3 2020

Nov 13, 2020

BUY
$79.44 - $178.51 $49,173 - $110,497
619 Added 7.82%
8,531 $924,000
Q2 2020

Aug 03, 2020

BUY
$13.86 - $83.61 $109,660 - $661,522
7,912 New
7,912 $659,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $629M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.